Village Farms International, Inc. Earnings Recaps
Village Farms' shares surged 16.8% post-earnings, driven by record cannabis revenues, strong margin expansion from their Delta facility, and significant growth in international export sales, notably benefiting from their EU GMP certified production advantage.
Key takeaways
- Achieved five consecutive quarters of positive net income and EPS since divesting legacy produce business.
- Nearly 10 percentage points year-over-year gross margin expansion attributed to record harvest yields, operating efficiencies, and favorable sales mix.
- Adjusted EBITDA rose meaningfully to $15.4 million, driven by a record Q2 cannabis segment performance.
- International export sales grew 74% year-over-year and 43% sequentially, supported by the world's largest EU GMP certified cannabis facility.
- Continued market share gains in Canadian convenience categories and strong positioning in German and broader European markets.
Village Farms' 1Q26 results beat expectations as total net sales rose 27% year-over-year, driven by a 171% surge in international export sales and sustained price stability in key markets. The 3.9% stock lift reflects investor approval of expanding global cannabis operations and capacity enhancements.
Key takeaways
- Total net sales increased 27% year-over-year, with a modest 2% sequential gain despite capacity constraints ahead of planned expansion.
- Adjusted EBITDA more than doubled (+118% YoY), supporting the company’s fourth consecutive quarter of positive net income.
- International exports reached nearly $15 million, up 171% year-over-year and 60% sequentially, led by growth in Germany where Village Farms holds multiple top cultivars.
- Pricing for EU GMP-compliant flower remained stable in international markets, contrasting with broader industry price compression.
- Expanded production capacity at the British Columbia facility now positions Village Farms as having the world’s largest EU GMP-certified cannabis operation, reinforcing competitive advantages.
Village Farms International reported strong third-quarter results, marked by a 21% increase in consolidated net sales year-over-year and record adjusted EBITDA margins, reinforcing its position as a leader in the cannabis market.
Key takeaways
- Consolidated net sales grew 21% year-over-year, reaching a record $64.1 million in the Canadian cannabis segment.
- Net income from continuing operations increased to $10.8 million, up nearly 10% sequentially from the previous quarter.
- Adjusted EBITDA hit a new high of $20.7 million, representing an adjusted EBITDA margin of 31%.
- International medical cannabis sales surged over 750% year-over-year, highlighting rapid growth in Germany and anticipated expansion into new markets.
- A 40 metric ton expansion project is underway, expected to increase annual production capacity by approximately 33% by early 2027.